These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 9531434

  • 61. Continuous infusion of levodopa-carbidopa intestinal gel in Parkinson's disease.
    Guthikonda LN, Lyons KE, Pahwa R.
    J Comp Eff Res; 2014 Jul; 3(4):331-3. PubMed ID: 25275230
    [Abstract] [Full Text] [Related]

  • 62. Comparison of apomorphine and levodopa infusions in four patients with Parkinson's disease with symptom fluctuations.
    Nyholm D, Constantinescu R, Holmberg B, Dizdar N, Askmark H.
    Acta Neurol Scand; 2009 May; 119(5):345-8. PubMed ID: 18822087
    [Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64. [Experience with continuous levodopa enteral infusion (Duodopa(®)) in patients with advanced Parkinson's disease in a secondary level hospital].
    Santos-García D, Macías M, Llaneza M, Fuster-Sanjurjo L, Echarri-Piudo A, Belmonte S, Blanco S.
    Neurologia; 2010 May; 25(9):536-43. PubMed ID: 21093702
    [Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66. Levodopa-responsive retrocollis on the background of choreic dyskinesia.
    Kataoka H, Sawada Y, Shimozato N, Inatomi S, Yoshiji H, Sugie K.
    Int J Neurosci; 2020 May; 130(5):461-463. PubMed ID: 31714814
    [Abstract] [Full Text] [Related]

  • 67. Duodenal and gastric delivery of levodopa in parkinsonism.
    Kurlan R, Nutt JG, Woodward WR, Rothfield K, Lichter D, Miller C, Carter JH, Shoulson I.
    Ann Neurol; 1988 Jun; 23(6):589-95. PubMed ID: 3408240
    [Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70. Controlled-release levodopa/carbidopa. I. Sinemet CR3 treatment of response fluctuations in Parkinson's disease.
    Cedarbaum JM, Breck L, Kutt H, McDowell FH.
    Neurology; 1987 Feb; 37(2):233-41. PubMed ID: 3808304
    [Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72. Dopamine dysregulation syndrome and punding in levodopa-carbidopa intestinal gel (LCIG) infusion: A serious but preventable complication.
    Salomone G, Marano M, di Biase L, Melgari JM, Di Lazzaro V.
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1124-5. PubMed ID: 26242552
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74. Carbidopa levodopa enteral suspension.
    Seeberger LC, Hauser RA.
    Expert Opin Pharmacother; 2015 Sep; 16(18):2807-17. PubMed ID: 26595228
    [Abstract] [Full Text] [Related]

  • 75. The cost-effectiveness of levodopa/carbidopa intestinal gel compared to standard care in advanced Parkinson's disease.
    Lowin J, Sail K, Baj R, Jalundhwala YJ, Marshall TS, Konwea H, Chaudhuri KR.
    J Med Econ; 2017 Nov; 20(11):1207-1215. PubMed ID: 28895769
    [Abstract] [Full Text] [Related]

  • 76. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
    Honig H, Antonini A, Martinez-Martin P, Forgacs I, Faye GC, Fox T, Fox K, Mancini F, Canesi M, Odin P, Chaudhuri KR.
    Mov Disord; 2009 Jul 30; 24(10):1468-74. PubMed ID: 19425079
    [Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.